Page last updated: 2024-09-05

enzastaurin and Pain

enzastaurin has been researched along with Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dudek, AZ; Ericson, ME; Farassati, F; Gallus, NJ; Jasinski, P; Terai, K; Zwolak, P	1

Other Studies

1 other study(ies) available for enzastaurin and Pain

Article	Year
Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis. Investigational new drugs, 2008, Volume: 26, Issue:1 Topics: Animals; Apoptosis; Bone Neoplasms; Caspases; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Female; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, SCID; Neovascularization, Pathologic; Osteoclasts; Pain; Protein Kinase C; Protein Kinase C beta; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; ras Proteins; Signal Transduction; Tumor Burden	2008

Article

Year

Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.

Investigational new drugs, 2008, Volume: 26, Issue:1

Topics: Animals; Apoptosis; Bone Neoplasms; Caspases; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Female; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, SCID; Neovascularization, Pathologic; Osteoclasts; Pain; Protein Kinase C; Protein Kinase C beta; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; ras Proteins; Signal Transduction; Tumor Burden

2008